Cerebrospinal fluid β-amyloid and tau proteins for the diagnosis of Alzheimer disease

被引：14

作者：

Knopman, D ^{[1
]}

机构：

[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA

来源：

ARCHIVES OF NEUROLOGY | 2001年 / 58卷 / 03期

关键词：

D O I：

10.1001/archneur.58.3.349

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：349 / 350

页数：2

共 15 条

[1] Participation in clinical trials and long-term outcomes in Alzheimer's disease [J].

Albert, SM ;

Sane, M ;

Marder, K ;

Jacobs, DM ;

Brandt, J ;

Albert, M ;

Stern, Y .

NEUROLOGY, 1997, 49 (01) :38-43

[2] Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice [J].

Andreasen, N ;

Minthon, L ;

Davidsson, P ;

Vanmechelen, E ;

Vanderstichele, H ;

Winblad, B ;

Blennow, K .

ARCHIVES OF NEUROLOGY, 2001, 58 (03) :373-379

[3] Clinicopathologic studies in cognitively healthy aging and Alzheimer disease - Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype [J].

Berg, L ;

McKeel, DW ;

Miller, JP ;

Storandt, M ;

Rubin, EH ;

Morris, JC ;

Baty, J ;

Coats, M ;

Norton, J ;

Goate, AM ;

Price, JL ;

Gearing, M ;

Mirra, SS ;

Saunders, AM .

ARCHIVES OF NEUROLOGY, 1998, 55 (03) :326-335

[4] CLINICAL-NEUROPATHOLOGICAL CORRELATIONS IN ALZHEIMERS-DISEASE AND RELATED DEMENTIAS [J].

GALASKO, D ;

HANSEN, LA ;

KATZMAN, R ;

WIEDERHOLT, W ;

MASLIAH, E ;

TERRY, R ;

HILL, R ;

LESSIN, P ;

THAL, LJ .

ARCHIVES OF NEUROLOGY, 1994, 51 (09) :888-895

[5] High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype [J].

Galasko, D ;

Chang, L ;

Motter, R ;

Clark, CM ;

Kaye, J ;

Knopman, D ;

Thomas, R ;

Kholodenko, D ;

Schenk, D ;

Lieberburg, I ;

Miller, B ;

Green, R ;

Basherad, R ;

Kertiles, L ;

Boss, MA ;

Seubert, P .

ARCHIVES OF NEUROLOGY, 1998, 55 (07) :937-945

[6] THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .10. NEUROPATHOLOGY CONFIRMATION OF THE CLINICAL-DIAGNOSIS OF ALZHEIMERS-DISEASE [J].

GEARING, M ;

MIRRA, SS ;

HEDREEN, JC ;

SUMI, SM ;

HANSEN, LA ;

HEYMAN, A .

NEUROLOGY, 1995, 45 (03) :461-466

[7] Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies [J].

Holmes, C ;

Cairns, N ;

Lantos, P ;

Mann, A .

BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 :45-50

[8] Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF [J].

Hulstaert, F ;

Blennow, K ;

Ivanoiu, A ;

Schoonderwaldt, HC ;

Riemenschneider, M ;

De Deyn, PP ;

Bancher, C ;

Cras, P ;

Wiltfang, J ;

Mehta, PD ;

Iqbal, K ;

Pottel, H ;

Vanmechelen, E ;

Vanderstichele, H .

NEUROLOGY, 1999, 52 (08) :1555-1562

[9]

Jobst K A, 1998, Int Psychogeriatr, V10, P271, DOI 10.1017/S1041610298005389

[10] Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series [J].

Lim, A ;

Tsuang, D ;

Kukull, W ;

Nochlin, D ;

Leverenz, J ;

McCormick, W ;

Bowen, J ;

Teri, L ;

Thompson, J ;

Peskind, ER ;

Raskind, M ;

Larson, EB .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (05) :564-569

← 1 2 →